A10E (p.Ala10Glu) variant of CDH1 (Cadherin-1)
A10E (p.Ala10Glu) in CDH1 (Cadherin-1) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as conflicting interpretations in the context of Hereditary diffuse gastric adenocarcinoma; Hereditary cancer-predisposing syndro. The available variant effect predictions contribute to a CATVariant prioritization score of 0.37 / 1. The record also includes published literature and structural context.
A10E (p.Ala10Glu) variant details
- p.Ala10Glu
- rs1375360857
- ClinGen CA396451352
- ClinVar RCV000709391
- ClinVar RCV000732057
- Conflicting interpretations
- Hereditary diffuse gastric adenocarcinoma; Hereditary cancer-predisposing syndro
- Missense
- Variant Prioritization Score for Impact Estimate 0.368
- AlphaMissense 0.42
- MetaLR 0.16
- MetaSVM -1.01
- PolyPhen-2 0.36
- SIFT 0.10
- MutPred 0.61
- ClinVar: Conflicting classifications of pathogenicity (Hereditary diffuse gastric adenocarcinoma; Hereditary cancer-pre)
- EBI: Likely benign
- UniProt: Likely benign
- Structural context available
- Cited in: A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic… (PMID 25394175)
- Cited in: American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. (PMID 17392385)